Microbiology: Current Research

All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal.
Reach Us +1 (202) 780-3397

Commentary - Microbiology: Current Research (2024) Volume 8, Issue 1

Unveiling the pathogenesis of emerging infectious diseases: From animal reservoirs to human transmission routes.

Jung Choi *

Department of Microbial Pathogenesis, University of Sydney, Australia

*Corresponding Author:
Jung Choi
Department of Microbial Pathogenesis, University of Sydney, Australia
E-mail: choi.jung@sydney.edu.au

Received: 01-Feb-2024, Manuscript No. AAMCR-24-135074; Editor assigned: 02-Feb-2024, PreQC No AAMCR-24-135074 (PQ) Reviewed:16-Feb-2024, QC No. AAMCR-24-135074 Revised:23-Feb-2024, Manuscript No. AAMCR-24-135074 (R); Published:28-Feb-2024, DOI:10.35841/aamcr-8.1.195

Citation: Cary L. Unlocking innovation: Synthetic biology approaches for designing novel microbial systems with industrial applications. J Micro Curr Res. 2024; 8(1):194

Visit for more related articles at Microbiology: Current Research

Introduction

In the intricate web of nature's balance, pathogens often find a way to leap from their natural hosts to infect humans, leading to the emergence of infectious diseases. Understanding the pathogenesis of these diseases is crucial for preventing outbreaks and devising effective control strategies. From zoonotic transmissions to human-specific adaptations, the journey of a pathogen from its reservoir to human hosts involves a series of complex interactions and adaptations [1].

At the heart of many emerging infectious diseases lies the concept of zoonosis, where pathogens naturally reside in animal populations but can infect humans under certain conditions. A prime example is the SARS-CoV-2 virus, believed to have originated in bats before spilling over to humans, possibly through an intermediate animal host. The process of zoonotic transmission often involves close contact between humans and infected animals, providing ample opportunity for pathogens to jump species barriers [2].

Upon entering the human population, the pathogen faces a new set of challenges. Adaptation to the human host environment is crucial for establishing successful transmission chains. This adaptation may involve genetic mutations or changes in the pathogen's behavior to enhance its ability to infect human cells and evade the host's immune responses. For instance, the influenza virus undergoes frequent genetic reassortment, allowing it to evade pre-existing immunity and potentially causing pandemics [3].

The transmission routes of emerging infectious diseases can vary widely, depending on the characteristics of the pathogen and the environment in which it spreads. Some diseases, like Ebola, primarily spread through direct contact with bodily fluids, making healthcare settings and burial practices high-risk environments. Others, such as the Zika virus, are primarily transmitted through vector bites, with mosquitoes serving as the main mode of transmission. Understanding these transmission routes is essential for implementing targeted control measures [4].

Environmental factors play a significant role in shaping the transmission dynamics of emerging infectious diseases. Climate change, urbanization, and habitat destruction can alter the distribution and behavior of both pathogens and their hosts, leading to the emergence of new disease hotspots. For example, deforestation and encroachment into wildlife habitats increase the likelihood of contact between humans and animal reservoirs, facilitating the spillover of pathogens like the Nipah virus [5].

Furthermore, human behavior and societal factors influence the spread of emerging infectious diseases. Globalization and increased travel have accelerated the spread of pathogens across continents, turning localized outbreaks into global pandemics. Socioeconomic disparities can exacerbate the impact of infectious diseases, with marginalized communities bearing the brunt of outbreaks due to limited access to healthcare and preventive measures [6].

The pathogenesis of emerging infectious diseases is not solely determined by biological factors but also by socio-cultural, economic, and political dimensions. Effective disease control requires a multi-faceted approach that addresses both the biological and social determinants of health. This includes strengthening healthcare infrastructure, promoting public health education, and addressing the root causes of health disparities [7, 8].

In recent years, advances in molecular biology, genomics, and epidemiology have revolutionized our understanding of the pathogenesis of emerging infectious diseases. Sequencing technologies allow researchers to track the evolution and transmission patterns of pathogens in real-time, providing valuable insights for outbreak response and control. Additionally, innovative vaccine platforms and antiviral therapies offer new tools for preventing and treating emerging infectious diseases [9, 10].

Conclusion

Despite these advancements, the threat of emerging infectious diseases continues to loom large, fueled by factors such as population growth, urbanization, and climate change. Vigilance and collaboration are essential in mitigating this threat, requiring coordinated efforts between governments, researchers, healthcare professionals, and communities worldwide. By unraveling the complex interplay between pathogens, hosts, and the environment, we can hope to better predict, prevent, and control the emergence of infectious diseases in the future.

References

  1. Schulze-Makuch D, Wagner D, Kounaves SP, et al. Transitory microbial habitat in the hyperarid Atacama Desert. PNAS. 2018;115(11):2670-5.

    2. Indexed at, Google Scholar, Cross Ref

  2. Thompson LR, Sanders JG, McDonald D, et al. A communal catalogue reveals Earth’s multiscale microbial diversity. Nature. 2017;551(7681):457-63.

    3. Indexed at, Google Scholar, Cross Ref

  3. Moss EL, Maghini DG, Bhatt AS. Complete, closed bacterial genomes from microbiomes using nanopore sequencing. Nat Biotechnol. 2020;38(6):701-7.

    4. Indexed at, Google Scholar, Cross Ref

  4. Bishara A, Moss EL, Kolmogorov M, et al. High-quality genome sequences of uncultured microbes by assembly of read clouds . Nat Biotechnol. 2018;36(11):1067-75.

    5. Indexed at, Google Scholar, Cross Ref

  5. Hilty M, Burke C, Pedro H, et al. Disordered microbial communities in asthmatic airways.PloS One. 2010;5(1):8578.

    6. Indexed at, Google Scholar,Cross Ref

  6. Macpherson AJ, Harris NL. Interactions between commensal intestinal bacteria and the immune system. Nat Rev Immunol. 2004;4(6):478-85.

    7. Indexed at, Google Scholar, Cross Ref

  7. Herzog C, Salès N, Etchegaray N, et al. Tissue distribution of bovine spongiform encephalopathy agent in primates after intravenous or oral infection. Lancet. 2004;363:422–7.

    8. Indexed at, Google Scholar, Cross Ref

  8. Stapleton F. Contact lens-related corneal infection in Australia. Clin Exp Optom. 2020;103(4)408-17.

    9. Indexed at, Google Scholar, Cross Ref

  9. Engels F. Pharmacology education : Reflections and challenges. Eur J Pharmacol. 2018;833:392-5.

    10. Indexed at, Google Scholar, Cross Ref

  10. Casadevall A, Pirofski LA. The damage-response framework of microbial pathogenesis. Nat Rev Microbiol. 2003;1(1):17-24.

    11. Indexed at, Google Scholar, Cross Ref

Get the App